Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

In 2025, significant changes will reshape healthcare for seniors in the United States, driven by the Inflation Reduction Act ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates ...

Farxiga became the first drug in the class to show efficacy in heart failure, in patients with or without type 2 diabetes, in the DAPA-HF trial. It was given a fast-track by the FDA in this ...

The thyroid medication levothyroxine should be taken on an empty stomach at around the same time every day. You should avoid eating or drinking for 30 minutes to one hour after taking it. There are ...

AZ is testing Farxiga for HFpEF as well, as are its main rivals Eli Lilly and Boehringer Ingelheim with their SGLT2 drug Jardiance (empagliflozin), with results due in the next year or so.

Mr. Jones added, “Annexon is leading the development of first-in-kind upstream complement medicines with significant opportunities across neuroinflammatory diseases that have yet to be unlocked. I ...

Paralytic drugs, or neuromuscular blocking agents (NMBAs), are powerful muscle relaxants used to prevent muscle movement during surgical procedures. They're also used during critical care, such as ...

More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...

Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...

Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...